Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-30.16	136.03	194.76
Graham Fair Price	-22.69	4.90	6.33
PEG	155.50	0.82	-0.32
Price/Book	3.78	2.11	2.03
Price/Cash Flow	-21.96	-708.21	-580.69
Prices/Earnings	-62.59	-29.80	-18.33
Price/Sales	0.12	21.00	20.97
Price/FCF	-21.96	-708.21	-580.69
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	95.65	0.07	0.04
Operating Margin	-75.90	0.01	-0.05
ROA	37.01	< 0.005	-0.01
ROE	-0.03	-0.02	36.17
ROIC	< 0.005	< 0.005	-70.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.24	0.34	-30.74
Dividends QOQ	0.01	-0.01	0.46
EBIT QOQ	-3.88	1.25	-67.90
EPS QOQ	-0.57	0.36	-36.36
FCF QOQ	-4.81	0.16	-96.57
Revenue QOQ	0.01	0.02	42.14
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-30.50	0.00	inf
Days Sales Outstanding (DSO)	27.31	26.65	-2.41
Inventory Turnover	-2.95	0.00	inf
Debt/Capitalization	0.63	0.57	-9.28
Quick Ratio	0.35	0.25	-29.42
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.02	7.76	-3.23
Cash	1.07	0.68	-37.06
Capex	-0.08	-0.05	39.43
Free Cash Flow	-0.03	-0.02	17.65
Revenue	0.78	0.78	0.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.28	0.25	-12.40
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	87.13	51.12	-41.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating